MAINZ BIOMED N.V. (MYNZ) Provides Business Update
MAINZ BIOMED N.V. (MYNZ) issued a business update covering recent developments.
planned for April 2026
🔍 Detailed Event Analysis:
AI Summary: Mainz Biomed N.V. is a molecular genetics diagnostic company specializing in the early detection of cancer. Robert P. Liscouski has been appointed Chairman of its Board of Directors. The Company will begin doing business as Quantum Cyber and trading under the symbol QUCY beginning on March 12, 2026.
Key Elements Identified:
Drugs/Compounds: specializing, planned, Change
Organizations: Board of Directors, Mainz Biomed N.V., Fox News
📋 MAINZ BIOMED N.V. (MYNZ) - Other Event
Filing Date: 2026-03-11
Accepted: 2026-03-11 07:35:06
Event Type: Other Event
Event Details:
🔍 Detailed Event Analysis:
AI Summary: Mainz Biomed N.V. is a molecular genetics diagnostic company specializing in the early detection of cancer. Robert P. Liscouski has been appointed Chairman of its Board of Directors. The Company will begin doing business as Quantum Cyber and trading under the symbol QUCY beginning on March 12, 2026.
Key Elements Identified:
💼 Business Developments:
No business developments data available.
Structured Data: